GENELUX CORP Contracts & Agreements
41 Contracts & Agreements
- Business Finance (15 contracts)
- Business Formation (1)
- Business Operations (1)
- Human Resources (11)
- Intellectual Property (4)
- Real Estate (4)
- Uncategorized (5)
- Form of Warrant to Purchase Common Stock issued on July 28, 2023 in connection with Converted Convertible Notes Payable (Filed With SEC on August 14, 2023)
- Form of Warrant to Purchase Common Stock issued on August 1, 2023 in connection with Converted Convertible Notes Payable (Filed With SEC on August 14, 2023)
- Executive Employment Offer Letter, by and between the Registrant and Ralph Smalling, MS, dated June 1, 2023 (Filed With SEC on August 14, 2023)
- Executive Employment Offer Letter, by and between the Registrant and Caroline Jewett, dated June 15, 2023 (Filed With SEC on August 14, 2023)
- Securities Purchase Agreement, dated June 9, 2023, by and among Genelux Corporation and the Purchasers (Filed With SEC on June 12, 2023)
- Executive Employment Offer Letter, by and between the Registrant and Thomas Zindrick, J.D., dated May 30, 2023 (Filed With SEC on June 2, 2023)
- Form of Warrant to Purchase Common Stock (Filed With SEC on May 15, 2023)
- Amendment to 2022 Unsecured Promissory Notes, by and among the Registrant and Existing Noteholders dated February 28, 2023 (Filed With SEC on May 15, 2023)
- Letter Agreement Amending the Umbrella Agreements, by and among the Registrant and Existing Noteholders dated April 4, 2023 (Filed With SEC on May 15, 2023)
- Sixteenth Amendment to Lease Agreement, by and between the Registrant and 3030 Bunker Hill Owner (DE) LLC, dated January 26, 2023 (Filed With SEC on May 15, 2023)
- Securities Purchase Agreement, dated May 12, 2023, by and among the Registrant and the Purchasers (Filed With SEC on May 15, 2023)
- Genelux Corporation 2022 Equity Incentive Plan (Filed With SEC on January 10, 2023)
- Genelux Corporation 2022 Employee Stock Purchase Plan (Filed With SEC on January 10, 2023)
- Offer Letter, by and between the registrant and Sean Ryder, dated September 29, 2021 (Filed With SEC on January 10, 2023)
- Offer Letter, by and between the registrant and Doug Samuelson, dated September 27, 2022 (Filed With SEC on January 10, 2023)
- Form of Underwriting Agreement (Filed With SEC on September 19, 2022)
- Form of Common Stock Certificate (Filed With SEC on August 29, 2022)
- Investors Rights Agreement, by and among the registrant and AbbVie, Inc. and Aladar Szalay, Ph.D., dated January 2010 (Filed With SEC on June 24, 2022)
- Form of Warrant to Purchase Common Stock issued to WDC Fund I, dated September 2020 (Filed With SEC on June 24, 2022)
- Agreement/Promissory Note, by and among the registrant and Jillian and Curtis Helmer, dated April 2016, as amended (Filed With SEC on June 24, 2022)
- Form of Umbrella Agreement Regarding Family Investments (Filed With SEC on June 24, 2022)
- Form of Convertible Note Purchase Agreement under the Umbrella Agreement (Filed With SEC on June 24, 2022)
- Genelux Corporation 2009 Equity Incentive Plan (Filed With SEC on June 24, 2022)
- Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Genelux Corporation 2009 Equity Incentive Plan (Filed With SEC on June 24, 2022)
- Genelux Corporation 2019 Equity Incentive Plan (Filed With SEC on June 24, 2022)
- Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Genelux Corporation 2019 Equity Incentive Plan (Filed With SEC on June 24, 2022)
- Genelux Corporation 2022 Equity Incentive Plan (Filed With SEC on June 24, 2022)
- Forms of Grant Notice, Stock Option Agreement and Notice of Exercise under the Genelux Corporation 2022 Equity Incentive Plan (Filed With SEC on June 24, 2022)
- Genelux Corporation 2022 Employee Stock Purchase Plan (Filed With SEC on June 24, 2022)
- Genelux Corporation Non-Employee Director Compensation Policy (Filed With SEC on June 24, 2022)
- Form of Indemnification Agreement by and between the registrant and its directors and executive officers (Filed With SEC on June 24, 2022)
- Offer Letter, by and between the registrant and Joseph Cappello, Ph.D., dated October 29, 2012 (Filed With SEC on June 24, 2022)
- Offer Letter, by and between the registrant and Tony Yu, Ph.D., dated January 2010, as amended (Filed With SEC on June 24, 2022)
- Lease Agreement, by and between the registrant and 1175-1177 Idaho Street, LLC, dated January 2012, as amended (Filed With SEC on June 24, 2022)
- Lease Agreement, by and between the registrant and Townsgate Property, LLC, dated as of August 2002 (Filed With SEC on June 24, 2022)
- Industrial/Commercial Multi-Tenant Lease, by and between the registrant and Marindustry Partners, LP, dated July 2018, as amended (Filed With SEC on June 24, 2022)
- Amended and Restated Limited Liability Company Agreement, by and between the registrant, TVAX Biomedical, Inc. and V2ACT Therapeutics, LLC, dated January 3, 2019 (Filed With SEC on June 24, 2022)
- License Agreement, by and between TVAX Biomedical, Inc. and V2ACT Therapeutics, LLC, dated June 18, 2021, as amended (Filed With SEC on June 24, 2022)
- License Agreement, by and between the registrant and V2ACT Therapeutics, LLC, dated June 18, 2021, as amended (Filed With SEC on June 24, 2022)
- License Agreement, by and between the registrant and Newsoara BioPharma Co, Ltd., dated September 27, 2021 (Filed With SEC on June 24, 2022)
- License Agreement, by and between the registrant and ELIAS Animal Health, LLC, dated November 15, 2021, as amended (Filed With SEC on June 24, 2022)
